An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. by James C Romero-Masters, Makoto Ohashi, Reza Djavadian, Mark R Eichelberg, Mitch Hayes, Jillian A Bristol, Shidong Ma, Erik A Ranheim, Jenny Gumperz, Eric C Johannsen, Shannon C Kenney

Get full text

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. by Nicholas Van Sciver, Makoto Ohashi, Dhananjay M Nawandar, Nicholas P Pauly, Denis Lee, Kathleen R Makielski, Jillian A Bristol, Sai Wah Tsao, Paul F Lambert, Eric C Johannsen, Shannon C Kenney

Get full text

ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells by Nicholas Van Sciver, Makoto Ohashi, Dhananjay M. Nawandar, Nicholas P. Pauly, Denis Lee, Kathleen R. Makielski, Jillian A. Bristol, Sai Wah Tsao, Paul F. Lambert, Eric C. Johannsen, Shannon C. Kenney

Get full text

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mi... by Chunrong Li, James C Romero-Masters, Shane Huebner, Makoto Ohashi, Mitchell Hayes, Jillian A Bristol, Scott E Nelson, Mark R Eichelberg, Nicholas Van Sciver, Erik A Ranheim, Rona S Scott, Eric C Johannsen, Shannon C Kenney

Get full text

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells. by Jillian A Bristol, Joshua Brand, Makoto Ohashi, Mark R Eichelberg, Alejandro Casco, Scott E Nelson, Mitchell Hayes, James C Romero-Masters, Dana C Baiu, Jenny E Gumperz, Eric C Johannsen, Huy Q Dinh, Shannon C Kenney

Get full text

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells by Jillian A. Bristol, Joshua Brand, Makoto Ohashi, Mark R. Eichelberg, Alejandro Casco, Scott E. Nelson, Mitchell Hayes, James C. Romero-Masters, Dana C. Baiu, Jenny E. Gumperz, Eric C. Johannsen, Huy Q. Dinh, Shannon C. Kenney

Get full text

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. by Jillian A Bristol, Reza Djavadian, Emily R Albright, Carrie B Coleman, Makoto Ohashi, Mitchell Hayes, James C Romero-Masters, Elizabeth A Barlow, Paul J Farrell, Rosemary Rochford, Robert F Kalejta, Eric C Johannsen, Shannon C Kenney

Get full text

Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes by Deo R. Singh, Scott E. Nelson, Abigail S. Pawelski, Juan A. Cantres-Velez, Alisha S. Kansra, Nicholas P. Pauly, Jillian A. Bristol, Mitchell Hayes, Makoto Ohashi, Alejandro Casco, Denis Lee, Stuart A. Fogarty, Paul F. Lambert, Eric C. Johannsen, Shannon C. Kenney

Get full text

Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes. by Deo R Singh, Scott E Nelson, Abigail S Pawelski, Juan A Cantres-Velez, Alisha S Kansra, Nicholas P Pauly, Jillian A Bristol, Mitchell Hayes, Makoto Ohashi, Alejandro Casco, Denis Lee, Stuart A Fogarty, Paul F Lambert, Eric C Johannsen, Shannon C Kenney

Get full text

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. by James C Romero-Masters, Shane M Huebner, Makoto Ohashi, Jillian A Bristol, Bayleigh E Benner, Elizabeth A Barlow, Gail L Turk, Scott E Nelson, Dana C Baiu, Nicholas Van Sciver, Erik A Ranheim, Jenny Gumperz, Nathan M Sherer, Paul J Farrell, Eric C Johannsen, Shannon C Kenney

Get full text